Key result
High CVA6 and increasing EV-A71 seropositivity in children support their use as HFMD vaccine candidates.
Why the study?
Children's immunity against specific serotypes indicating past infection should be considered when selecting candidate serotypes for multivalent HFMD vaccine development.
What is the age-stratified seroprevalence of neutralizing antibodies against candidate serotypes of Enterovirus vaccines among Korean children?
Cross-Sectional (n=220)
What is the age-stratified seroprevalence of neutralizing antibodies against candidate serotypes of Enterovirus vaccines among Korean children?
EV-A71 and CVA6 are suitable candidate serotypes for HFMD vaccine development in Korea based on age-stratified seroprevalence.
Answers are grounded in this paper and cite their sources.
May guide HFMD vaccine candidate selection in Korea; leaves open need for prospective efficacy trials.
A71 (EV-A71) and coxsackieviruses A6, A10, and A16 (CVA6, CVA10, and CVA16) are the major serotypes causing HFMD. Asian countries, including Korea, are currently developing a multivalent vaccine targeting these serotypes. However, the immunity of children against specific serotypes, indicating past infection, should also be considered while selecting candidate serotypes for vaccine development. Therefore, we aimed to identify the age-stratified serological statuses of Korean children to determine candidate serotypes for HFMD vaccine development. This study included 220 participants, categorized into four age groups, 7 months-2 years, 3-5 years, 6-10 years, and 11-15 years. A neutralization test was performed to quantitate the neutralizing antibodies (NtAbs) in the sera of the participants. Only EV-A71 and CVA6 were found suitable as candidate serotypes for vaccine development, whereas further study is needed for CVA10 and CVA16. The highest seropositivity and NtAb titer ranges were observed for CVA6 in all age groups, suggesting that the participants had been predominantly exposed to CVA6. For EV-A71, seropositivity and NtAb titer ranges steadily increased with age, suggesting that children were currently exposed to EV-A71. For CVA10, the 3-5 years group showed the highest seropositivity rate and higher NtAb titer ranges than the older age groups, indicating that the exposure to CVA10 had mainly occurred in recent years. Future studies will identify whether the exposure to CVA10 was transient or will continue. For CVA16, seropositivity and NtAb titer ranges were generally low, indicating that only a few participants had been exposed to CVA16. We identified discrepancies between the sentinel surveillance data and our findings. This study provides a new perspective for HFMD vaccine development and policy making in Asian countries.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted a cross-sectional in Hand, foot, and mouth disease (HFMD) (n=220). Serological analysis of 220 Korean children revealed high seropositivity for CVA6 across all ages and increasing seropositivity for EV-A71 with age, supporting their use as HFMD vaccine candidates.
Synapse has enriched 10 related papers. Consider them for comparative context: